Literature DB >> 31858408

Immune Characterization in Aneurysmal Subarachnoid Hemorrhage Reveals Distinct Monocytic Activation and Chemokine Patterns.

Malte Mohme1, Thomas Sauvigny2, Marius Marc-Daniel Mader2, Nils Schweingruber3, Cecile L Maire2, Alessandra Rünger2, Franz Ricklefs2, Jan Regelsberger2, Nils Ole Schmidt2, Manfred Westphal2, Katrin Lamszus2, Eva Tolosa4, Patrick Czorlich2.   

Abstract

The pathophysiology of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) is incompletely understood. Intrathecal activation of inflammatory immune cells is suspected to play a major role for the induction of DCI. The aim of this study is to identify immune cell subsets and mediators involved in the pathogenesis of DCI. We prospectively collected blood and CSF from 25 patients with aSAH at early and late time points. We performed multicolor flow cytometry of peripheral blood and CSF, analyzing immune cell activation and pro-inflammatory cyto- and chemokines. In addition to the primary immune analysis, we retrospectively analyzed immune cell dynamics in the CSF of all our SAH patients. Our results show an increased monocyte infiltration secondary to aneurysm rupture in patients with DCI. Infiltrating monocytes are defined by a non-classical (CD14dim CD16+) phenotype at early stages. The infiltration is most likely triggered by the intrathecal immune activation. Here, high levels of pro-inflammatory chemokines, such as CXCL1, CXCL9, CXCL10, and CXCL11, are detected. The intrathecal cellular activation profile of monocytes was defined by upregulation of CD163 and CD86 on monocytes and a presumable later differentiation into antigen-presenting plasmacytoid dendritic cells (pDCs) and hemosiderophages. Peripheral immune activation was reflected by CD69 upregulation on T cells. Analysis of DCI prevalence, Hunt and Hess grade, and clinical outcome correlated with the degree of immune activation. We demonstrate that monocytes and T cells are activated intrathecally after aSAH and mediate a local inflammatory response which is presumably driven by chemokines. Our data shows that the distinct pattern of immune activation correlates with the prevalence of DCI, indicating a pathophysiological connection to the incidence of vasospasm.

Entities:  

Keywords:  Cerebrospinal fluid; DCI; Delayed cerebral ischemia; Immune profile; Immunology; Subarachnoid hemorrhage; Vasospasm

Year:  2019        PMID: 31858408     DOI: 10.1007/s12975-019-00764-1

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  12 in total

1.  Monocyte-based inflammatory indices predict outcomes following aneurysmal subarachnoid hemorrhage.

Authors:  James Feghali; Jennifer Kim; Abhishek Gami; Sarah Rapaport; Justin M Caplan; Cameron G McDougall; Judy Huang; Rafael J Tamargo; Christopher M Jackson
Journal:  Neurosurg Rev       Date:  2021-04-10       Impact factor: 3.042

2.  Deep Phenotyping of T-Cells Derived From the Aneurysm Wall in a Pediatric Case of Subarachnoid Hemorrhage.

Authors:  Giorgia Moschetti; Chiara Vasco; Francesca Clemente; Eugenia Galeota; Marco Carbonara; Mauro Pluderi; Marco Locatelli; Nino Stocchetti; Sergio Abrignani; Elisa R Zanier; Fabrizio Ortolano; Tommaso Zoerle; Jens Geginat
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

Review 3.  [Artificial intelligence in neurocritical care].

Authors:  N Schweingruber; C Gerloff
Journal:  Nervenarzt       Date:  2021-01-24       Impact factor: 1.214

Review 4.  The role of L-arginine metabolism in neurocritical care patients.

Authors:  Marius Marc-Daniel Mader; Patrick Czorlich
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

5.  Monocyte Count on Admission Is Predictive of Shunt-Dependent Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Joshua A Cuoco; Evin L Guilliams; Brendan J Klein; Mark R Witcher; Eric A Marvin; Biraj M Patel; John J Entwistle
Journal:  Front Surg       Date:  2022-04-28

Review 6.  Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders.

Authors:  Rezan Ashayeri Ahmadabad; Zahra Mirzaasgari; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

7.  CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients.

Authors:  Rosaria Greco; Chiara Demartini; Anna Maria Zanaboni; Elena Tumelero; Alessandra Persico; Elisa Candeloro; Andrea Morotti; Diana Amantea; Cristina Tassorelli
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 8.  The Role of Thrombin in Brain Injury After Hemorrhagic and Ischemic Stroke.

Authors:  Fenghui Ye; Hugh J L Garton; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2020-09-29       Impact factor: 6.800

Review 9.  A Review of Hematoma Components Clearance Mechanism After Subarachnoid Hemorrhage.

Authors:  Pengjie Pan; Li Xu; Hongrong Zhang; Yuan Liu; Xiaocheng Lu; Gang Chen; Hailiang Tang; Jiang Wu
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

10.  Temporal patterns of inflammation-related proteins measured in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage using multiplex Proximity Extension Assay technology.

Authors:  Pavlos Vlachogiannis; Lars Hillered; Per Enblad; Elisabeth Ronne-Engström
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.